首页> 外文期刊>Disease models & mechanisms: DMM >Accelerated renal disease is associated with the development of metabolic syndrome in a glucolipotoxic mouse model
【24h】

Accelerated renal disease is associated with the development of metabolic syndrome in a glucolipotoxic mouse model

机译:糖脂毒性小鼠模型中加速的肾脏疾病与代谢综合征的发展有关

获取原文
           

摘要

Individuals with metabolic syndrome are at high risk of developing chronic kidney disease (CKD) through unclear pathogenic mechanisms. Obesity and diabetes are known to induce glucolipotoxic effects in metabolically relevant organs. However, the pathogenic role of glucolipotoxicity in the aetiology of diabetic nephropathy is debated. We generated a murine model, the POKO mouse, obtained by crossing the peroxisome proliferator-activated receptor gamma 2 (PPARγ2) knockout (KO) mouse into a genetically obese ob/ob background. We have previously shown that the POKO mice showed: hyperphagia, insulin resistance, hyperglycaemia and dyslipidaemia as early as 4 weeks of age, and developed a complete loss of normal β-cell function by 16 weeks of age. Metabolic phenotyping of the POKO model has led to investigation of the structural and functional changes in the kidney and changes in blood pressure in these mice. Here we demonstrate that the POKO mouse is a model of renal disease that is accelerated by high levels of glucose and lipid accumulation. Similar to ob/ob mice, at 4 weeks of age these animals exhibited an increased urinary albumin:creatinine ratio and significantly increased blood pressure, but in contrast showed a significant increase in the renal hypertrophy index and an associated increase in p27Kip1 expression compared with their obese littermates. Moreover, at 4 weeks of age POKO mice showed insulin resistance, an alteration of lipid metabolism and glomeruli damage associated with increased transforming growth factor beta (TGFβ) and parathyroid hormone-related protein (PTHrP) expression. At this age, levels of proinflammatory molecules, such as monocyte chemoattractant protein-1 (MCP-1), and fibrotic factors were also increased at the glomerular level compared with levels in ob/ob mice. At 12 weeks of age, renal damage was fully established. These data suggest an accelerated lesion through glucolipotoxic effects in the renal pathogenesis in POKO mice.
机译:代谢综合症患者的致病机制尚不清楚,因此罹患慢性肾脏病(CKD)的风险很高。已知肥胖和糖尿病会在代谢相关器官中诱发糖脂毒性作用。然而,糖脂毒性在糖尿病性肾病病因中的致病作用尚有争议。我们通过将过氧化物酶体增殖物激活受体γ2(PPARγ2)基因敲除(KO)小鼠杂交到遗传肥胖的ob / ob背景中,获得了一种小鼠模型POKO小鼠。先前我们已经表明,POKO小鼠早在4周龄时就表现出:食欲亢进,胰岛素抵抗,高血糖症和血脂异常,到16周龄时已完全丧失正常的β细胞功能。 POKO模型的代谢表型已导致研究这些小鼠中肾脏的结构和功能变化以及血压变化。在这里,我们证明POKO小鼠是肾脏疾病的模型,可通过高水平的葡萄糖和脂质积累而加速。与ob / ob小鼠类似,在4周龄时,这些动物的尿白蛋白:肌酐比值增加且血压显着升高,但与之相比,它们的肾脏肥大指数显着增加,并且p27Kip1表达也随之增加肥胖的同窝仔。此外,在4周龄时,POKO小鼠表现出胰岛素抵抗,脂质代谢改变和肾小球损害,与转化生长因子β(TGFβ)和甲状旁腺激素相关蛋白(PTHrP)表达增加有关。在这个年龄,与ob / ob小鼠的水平相比,肾小球水平的促炎分子(例如单核细胞趋化蛋白-1(MCP-1)和纤维化因子)的水平也增加了。在12周龄时,肾损伤已完全确立。这些数据表明在POKO小鼠的肾脏发病中,通过糖脂毒性作用引起的病变加速。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号